128 related articles for article (PubMed ID: 24853767)
21. Molecular docking/dynamics studies of Aurora A kinase inhibitors.
Talele TT; McLaughlin ML
J Mol Graph Model; 2008 Jun; 26(8):1213-22. PubMed ID: 18096419
[TBL] [Abstract][Full Text] [Related]
22. Indolin-2-one p38α inhibitors I: design, profiling and crystallographic binding mode.
Eastwood P; González J; Gómez E; Vidal B; Caturla F; Roca R; Balagué C; Orellana A; Domínguez M
Bioorg Med Chem Lett; 2011 Jul; 21(14):4130-3. PubMed ID: 21696951
[TBL] [Abstract][Full Text] [Related]
23. Structure-based optimization and biological evaluation of trisubstituted pyrazole as a core structure of potent ROS1 kinase inhibitors.
Park BS; Al-Sanea MM; Abdelazem AZ; Park HM; Roh EJ; Park HM; Yoo KH; Sim T; Tae JS; Lee SH
Bioorg Med Chem; 2014 Aug; 22(15):3871-8. PubMed ID: 24997577
[TBL] [Abstract][Full Text] [Related]
24. Cysteine mapping in conformationally distinct kinase nucleotide binding sites: application to the design of selective covalent inhibitors.
Leproult E; Barluenga S; Moras D; Wurtz JM; Winssinger N
J Med Chem; 2011 Mar; 54(5):1347-55. PubMed ID: 21322567
[TBL] [Abstract][Full Text] [Related]
25. Selective KIT inhibitor KI-328 and HSP90 inhibitor show different potency against the type of KIT mutations recurrently identified in acute myeloid leukemia.
Tsujimura A; Kiyoi H; Shiotsu Y; Ishikawa Y; Mori Y; Ishida H; Toki T; Ito E; Naoe T
Int J Hematol; 2010 Nov; 92(4):624-33. PubMed ID: 20890793
[TBL] [Abstract][Full Text] [Related]
26. Developing and Characterization of Chemically Modified RNA Aptamers for Targeting Wild Type and Mutated c-KIT Receptor Tyrosine Kinases.
Shraim AS; Hunaiti A; Awidi A; Alshaer W; Ababneh NA; Abu-Irmaileh B; Odeh F; Ismail S
J Med Chem; 2020 Mar; 63(5):2209-2228. PubMed ID: 31369705
[TBL] [Abstract][Full Text] [Related]
27. Molecular editing of kinase-targeting resorcylic acid lactones (RAL): Fluoroenone RAL.
Jogireddy R; Barluenga S; Winssinger N
ChemMedChem; 2010 May; 5(5):670-3. PubMed ID: 20209566
[No Abstract] [Full Text] [Related]
28. Investigation of the differences in activity between hydroxycycloalkyl N1 substituted pyrazole derivatives as inhibitors of B-Raf kinase by using docking, molecular dynamics, QM/MM, and fragment-based de novo design: study of binding mode of diastereomer compounds.
Caballero J; Alzate-Morales JH; Vergara-Jaque A
J Chem Inf Model; 2011 Nov; 51(11):2920-31. PubMed ID: 22011048
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and evaluation of highly selective pyridone-based class II MET inhibitors.
She N; Zhuo L; Jiang W; Zhu X; Wang J; Ming Z; Zhao X; Cong X; Huang W
Bioorg Med Chem Lett; 2014 Aug; 24(15):3351-5. PubMed ID: 24951334
[TBL] [Abstract][Full Text] [Related]
30. Scaffold oriented synthesis. Part 2: Design, synthesis and biological evaluation of pyrimido-diazepines as receptor tyrosine kinase inhibitors.
Gracias V; Ji Z; Akritopoulou-Zanze I; Abad-Zapatero C; Huth JR; Song D; Hajduk PJ; Johnson EF; Glaser KB; Marcotte PA; Pease L; Soni NB; Stewart KD; Davidsen SK; Michaelides MR; Djuric SW
Bioorg Med Chem Lett; 2008 Apr; 18(8):2691-5. PubMed ID: 18362070
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and biological evaluation of 5-benzylidene-2-iminothiazolidin-4-ones as selective GSK-3β inhibitors.
Arfeen M; Bhagat S; Patel R; Prasad S; Roy I; Chakraborti AK; Bharatam PV
Eur J Med Chem; 2016 Oct; 121():727-736. PubMed ID: 27423119
[TBL] [Abstract][Full Text] [Related]
32. 7-Azaindole: A Versatile Scaffold for Developing Kinase Inhibitors.
Irie T; Sawa M
Chem Pharm Bull (Tokyo); 2018; 66(1):29-36. PubMed ID: 29311509
[TBL] [Abstract][Full Text] [Related]
33. Identification of novel
Elasbali AM; Al-Soud WA; Elfaki EM; Alanazi HH; Alharbi B; Alharethi SH; Anwer K; Mohammad T; Hassan MI
J Biomol Struct Dyn; 2024 Jul; 42(11):5982-5994. PubMed ID: 37403288
[TBL] [Abstract][Full Text] [Related]
34. From the insoluble dye indirubin towards highly active, soluble CDK2-inhibitors.
Jautelat R; Brumby T; Schäfer M; Briem H; Eisenbrand G; Schwahn S; Krüger M; Lücking U; Prien O; Siemeister G
Chembiochem; 2005 Mar; 6(3):531-40. PubMed ID: 15742375
[No Abstract] [Full Text] [Related]
35. Discovery of 8-Amino-Substituted 2-Phenyl-2,7-Naphthyridinone Derivatives as New c-Kit/VEGFR-2 Kinase Inhibitors.
Sun H; Zhuo L; Dong H; Huang W; She N
Molecules; 2019 Dec; 24(24):. PubMed ID: 31817456
[TBL] [Abstract][Full Text] [Related]
36. Identification of novel inhibitors of tropomyosin-related kinase A through the structure-based virtual screening with homology-modeled protein structure.
Park H; Chi O; Kim J; Hong S
J Chem Inf Model; 2011 Nov; 51(11):2986-93. PubMed ID: 22017333
[TBL] [Abstract][Full Text] [Related]
37. Rational Design, Synthesis, and Biological Evaluation of 7-Azaindole Derivatives as Potent Focused Multi-Targeted Kinase Inhibitors.
Daydé-Cazals B; Fauvel B; Singer M; Feneyrolles C; Bestgen B; Gassiot F; Spenlinhauer A; Warnault P; Van Hijfte N; Borjini N; Chevé G; Yasri A
J Med Chem; 2016 Apr; 59(8):3886-905. PubMed ID: 27010810
[TBL] [Abstract][Full Text] [Related]
38. 4-Phenyl-7-azaindoles as potent and selective IKK2 inhibitors.
Liddle J; Bamborough P; Barker MD; Campos S; Cousins RP; Cutler GJ; Hobbs H; Holmes DS; Ioannou C; Mellor GW; Morse MA; Payne JJ; Pritchard JM; Smith KJ; Tape DT; Whitworth C; Williamson RA
Bioorg Med Chem Lett; 2009 May; 19(9):2504-8. PubMed ID: 19349179
[TBL] [Abstract][Full Text] [Related]
39. Discovery of aryl aminoquinazoline pyridones as potent, selective, and orally efficacious inhibitors of receptor tyrosine kinase c-Kit.
Hu E; Tasker A; White RD; Kunz RK; Human J; Chen N; Bürli R; Hungate R; Novak P; Itano A; Zhang X; Yu V; Nguyen Y; Tudor Y; Plant M; Flynn S; Xu Y; Meagher KL; Whittington DA; Ng GY
J Med Chem; 2008 Jun; 51(11):3065-8. PubMed ID: 18447379
[TBL] [Abstract][Full Text] [Related]
40. Structure-aided optimization of kinase inhibitors derived from alsterpaullone.
Kunick C; Zeng Z; Gussio R; Zaharevitz D; Leost M; Totzke F; Schächtele C; Kubbutat MH; Meijer L; Lemcke T
Chembiochem; 2005 Mar; 6(3):541-9. PubMed ID: 15696597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
